Intuitive Surgical, Inc. (ISRG)
NASDAQ: ISRG · Real-Time Price · USD
572.47
+10.58 (1.88%)
At close: Dec 19, 2025, 4:00 PM EST
572.71
+0.24 (0.04%)
After-hours: Dec 19, 2025, 7:59 PM EST
Intuitive Surgical Revenue
Intuitive Surgical had revenue of $2.51B in the quarter ending September 30, 2025, with 22.91% growth. This brings the company's revenue in the last twelve months to $9.61B, up 22.18% year-over-year. In the year 2024, Intuitive Surgical had annual revenue of $8.35B with 17.24% growth.
Revenue (ttm)
$9.61B
Revenue Growth
+22.18%
P/S Ratio
21.28
Revenue / Employee
$614,657
Employees
15,638
Market Cap
202.94B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.35B | 1.23B | 17.24% |
| Dec 31, 2023 | 7.12B | 901.90M | 14.49% |
| Dec 31, 2022 | 6.22B | 512.10M | 8.97% |
| Dec 31, 2021 | 5.71B | 1.35B | 31.01% |
| Dec 31, 2020 | 4.36B | -120.10M | -2.68% |
| Dec 31, 2019 | 4.48B | 754.30M | 20.25% |
| Dec 31, 2018 | 3.72B | 586.00M | 18.67% |
| Dec 31, 2017 | 3.14B | 431.70M | 15.95% |
| Dec 31, 2016 | 2.71B | 322.10M | 13.51% |
| Dec 31, 2015 | 2.38B | 252.70M | 11.85% |
| Dec 31, 2014 | 2.13B | -133.40M | -5.89% |
| Dec 31, 2013 | 2.27B | 86.30M | 3.96% |
| Dec 31, 2012 | 2.18B | 421.50M | 23.99% |
| Dec 31, 2011 | 1.76B | 344.30M | 24.37% |
| Dec 31, 2010 | 1.41B | 360.80M | 34.29% |
| Dec 31, 2009 | 1.05B | 177.30M | 20.27% |
| Dec 31, 2008 | 874.90M | 274.07M | 45.62% |
| Dec 31, 2007 | 600.83M | 228.15M | 61.22% |
| Dec 31, 2006 | 372.68M | 145.34M | 63.93% |
| Dec 31, 2005 | 227.34M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
ISRG News
- 14 days ago - Intuitive Surgical: Is The Smart Money Moving In? - Forbes
- 14 days ago - Is It Time To Buy Intuitive Surgical Stock? - Forbes
- 14 days ago - Fisher, Cohen & Laffont's Robotics Pick Just Triggered A Golden Cross - Benzinga
- 17 days ago - Intuitive Surgical: Da Vinci Delivers, Double-Digit EPS Growth, Golden Cross - Seeking Alpha
- 23 days ago - Can Intuitive Surgical Still Be A Good Buy? - Forbes
- 4 weeks ago - PGIM Jennison Health Sciences Fund Q3 2025 Contributors And Detractors - Seeking Alpha
- 5 weeks ago - Baron Fifth Avenue Growth Fund Q3 2025 Performance Update - Seeking Alpha
- 5 weeks ago - RiverPark Long/Short Opportunity Fund: Q3 2025 Top And Bottom Performers - Seeking Alpha